BOSTON, March 21 /PRNewswire/ -- Nova Group will be sponsoring the Welcome Reception today, Monday, March 21, 2005 6:00-8:00pm, for this important conference on combination drug/device therapies being held in Pittsburgh March 21-23.
This Convergence of combination drug/device therapies is already a multi-billion dollar commercial reality with drug-eluting stents, but this is only the first step in a market segment that is poised for explosive growth.
Nova Group is uniquely qualified to provide assistance to companies developing new technologies in this area of Convergence, since the company’s principals have been involved in the development and launch of numerous drug, device and combination drug/device therapies for more than a decade. Our clients include global leaders in medical devices, pharmaceuticals and biotech. Specific product categories include: drug-eluting stents, targeted nanotechnology cancer therapies, combination pain management therapies, as well as others.
“Nova Group’s expertise has deepened as it has provided an extensive range of professional services to the leading manufacturers of drug-eluting stents, and other cardiology products, for more than a decade. We have been pleased to work closely with these companies before, during and after the launch of drug-eluting stents,” said David Wagner, CEO of Nova Group, “And we have also been pleased to work extensively with other leading companies developing entirely new combination drug/device therapies. Overall, I believe that this area will demonstrate explosive growth over the next decade, and Nova Group’s clients will continue to benefit from our deep experience in this market space.”
About Nova Group:
Nova Group is a leading strategic research and consulting company, advising Fortune 500 companies in medical devices, specialty pharmaceuticals and biotechnology. Nova Group also advises a select group of early-stage companies in these segments. Nova Group’s principals have been providing professional services to leading companies in the life sciences field since 1994. In 2004 alone, Nova Group interviewed more than 10,000 medical professionals across 15 countries in the process of completing dozens of client engagements.
This release was issued through Major Newswire (http://www.majornewswire.com/)
Nova Group
CONTACT: Market Research, Alicia Dowdell, Partner, ext. 203,adowdell@novamedx.com, or Management Consulting, Derek Burnham, Partner,ext. 202, dburnham@novamedx.com, both of Nova Group, +1-617-426-0550
Web site: http://www.majornewswire.com/
Web site: http://www.novamedx.com/
